LifeScience Biologics
Aptamer Group’s discovery platform is enabling new solutions across the life sciences.
How is success in the discovery of small molecule ligands increased with the Optimer platform? The Optimer platform incorporates three se...
January 04, 2023 | News
Biocytogen and Hansoh Pharma Announce an Antibody License Agreement
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", SEHK : 02315) a clinical-stage biotechnology company with a focus on the antibody discovery a...
January 03, 2023 | News
Merck Announces Collaboration With Mersana Therapeutics to Develop Novel Immunostimulatory Antibody-Drug Conjugates
Collaboration complements Merck’s internal expertise and in-house ADC approach Companies focused on discovering novel STING-agonist ADCs for up to...
December 23, 2022 | News
Pictor announces important COVID-19 trial to map immunity profile of New Zealanders
Pictor, a global leader in immunodiagnostics, today announced an important research project – the Pictor Antibody Clinical Trial (PACT-19) – wh...
December 22, 2022 | News
Genome Insight Develops ‘StreamSeq’ Technology for High-speed Whole Genome Analysis
Genome Insight, a precision medicine whole genome platform company, announced on the 19th that it has been granted a patent for its ‘StreamSeq’...
December 21, 2022 | News
Novavax Announces Pricing of its $150 Million Convertible Debenture Offering
The Notes are currently being offered and sold only to persons who are reasonably qualified institutional purchasers within the meaning of Rule 144A under ...
December 19, 2022 | News
Prenetics Acquires ACT Genomics
Acquisition to bring germline and somatic testing, cell-free DNA-based (liquid biopsy), and tissue-genomic profiling onto a single platform Cancer genom...
December 16, 2022 | News
Eisai and Washington University School of Medicine in St. Louis Enter Into Comprehensive Research Collaboration Agreement Aiming to Create New Therapies for Neurodegenerative Diseases
Washington University is world leading in research on prevention, diagnosis, biomarkers and treatment of neurodegenerative diseases. The two organizations ...
December 15, 2022 | News
Bio Elpida Acquisition Brings GMP Fill and Finish Capacity to Polyplus
“Bio Elpida is certified by the French Health Authorities (ANSM) as a Pharmaceutical Company to manufacture Active Pharmaceutical Ingredients and Adv...
December 15, 2022 | News
Over £175 million for cutting-edge genomics research to help boost diagnosis treatment for patients
£105 million to speed up diagnosis of rare genetic diseases in newborns, potentially resulting in life-saving interventions for thousands of babies...
December 15, 2022 | News
Merck Signs MoU with Synplogen to Accelerate Development and Manufacturing of Viral Vector-based Gene Therapy Applications
Merck’s Millipore® CTDMO Services (Contract Testing, Development and Manufacturing Organization) to streamline viral vector development and pro...
December 14, 2022 | News
Biosion Announces Research Collaboration with ImmunoGen to Create Novel Antibody-Drug Conjugates
Biosion USA, Inc. (Biosion), a global R&D biotechnology company, today announced an exploratory research collaboration to create antibody-drug con...
December 14, 2022 | News
New startup Graegis Pharmaceuticals to prevent skin and mucosa side effects of radiotherapy
Graegis Pharmaceuticals, a startup developing new therapies aimed at preventing the side effects of radiotherapies on healthy skin and mucosa, has been fou...
December 13, 2022 | News
Catalent Opens One of the World’s Largest Commercial-Scale Cell Therapy Manufacturing Facilities
Catalent, the global leader in enabling biopharma, cell, gene and consumer health partners to optimize development, launch, and supply of better patient tr...
December 09, 2022 | News
Most Read
- Biotech and Biopharma Industry Trends: What to Watch for in 2024
- Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2024
- 2024's Biopharma Roadmap: Top 24 Biopharma Trends to Watch in 2024
- Breakthroughs Unveiled: A Year of Groundbreaking Novel Drug Approvals in 2023
- Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024
Bio Jobs
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
- Cordlife Accelerates Lab and Technical Staff Recruitment to Rebuild Foundation and Strengthen Core Processes in Singapore
- Padraig McDonnell Takes Helm as Agilent Technologies' New CEO, Pledges to Elevate Scientific Impact
- Agilent Singapore and Malaysia Hosts CEO Transition Event: Celebrating Leadership and Welcoming New CEO
- Leica Microsystems Announces Vacancy for Senior Imaging FPGA Testing Engineer in Singapore
- Glen Godresse Takes Helm as CEO of Menarini Asia-Pacific
News
Editor Picks
